Lung Cancer
A PHASE 2 STUDY OF ALISERTIB IN PATIENTS WITH EXTENSIVE SMALL CELL LUNG CANCER (PUMA-ALI-4201)
- Details
ClinicalTrials.gov ID:
NCT06095505
Diagnosis Type:
NA
USOR Number:
- Address
,
P: